200 related articles for article (PubMed ID: 34218990)
1. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory.
Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E;
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2661-2668. PubMed ID: 34218990
[TBL] [Abstract][Full Text] [Related]
2. Incidence of diabetes mellitus in Italy in year 2018. A nationwide population-based study of the ARNO Diabetes Observatory.
Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E;
Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2338-2344. PubMed ID: 34074587
[TBL] [Abstract][Full Text] [Related]
3. Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0-29 years: The population-based CINECA-SID ARNO Observatory, 2002-2012.
Bruno G; Pagano E; Rossi E; Cataudella S; De Rosa M; Marchesini G; Miccoli R; Vaccaro O; Bonora E
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1104-1111. PubMed ID: 27817991
[TBL] [Abstract][Full Text] [Related]
4. The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database.
Liatis S; Dafoulas GE; Kani C; Politi A; Litsa P; Sfikakis PP; Makrilakis K
Diabetes Res Clin Pract; 2016 Aug; 118():162-7. PubMed ID: 27372056
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes.
Levin PA; Wei W; Zhou S; Xie L; Baser O
J Manag Care Spec Pharm; 2014 May; 20(5):501-12. PubMed ID: 24761822
[TBL] [Abstract][Full Text] [Related]
6. Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010-2020: A retrospective population-based cohort study.
Mahmoud F; Mueller T; Mullen A; Sainsbury C; Rushworth GF; Kurdi A
Diabetes Obes Metab; 2024 Jul; 26(7):2684-2694. PubMed ID: 38558305
[TBL] [Abstract][Full Text] [Related]
7. Approaches to treatment 1: How is type 2 diabetes actually treated?
Bloomgarden ZT
J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568
[No Abstract] [Full Text] [Related]
8. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients.
Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC
Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800
[TBL] [Abstract][Full Text] [Related]
9. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
[TBL] [Abstract][Full Text] [Related]
10. Employing observational method for prospective data collection: A case study for analyzing diagnostic process and evaluating efficacy of TCM treatments for diabetes mellitus.
Gu X; Huang N; Gu J; Joshi MK; Wang H
J Ethnopharmacol; 2016 Nov; 192():516-523. PubMed ID: 27616025
[TBL] [Abstract][Full Text] [Related]
11. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
[TBL] [Abstract][Full Text] [Related]
12. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
[TBL] [Abstract][Full Text] [Related]
13. Treatment persistence in the use of basal insulins in Poland and Germany
.
Rathmann W; Czech M; Franek E; Kostev K
Int J Clin Pharmacol Ther; 2017 Feb; 55(2):119-125. PubMed ID: 27879196
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006.
Norgaard ML; Andersson C; Hansen PR; Andersen SS; Vaag A; Schramm TK; Folke F; Køber L; Torp-Pedersen C; Gislason GH
Cardiovasc Diabetol; 2011 Jan; 10():5. PubMed ID: 21247456
[TBL] [Abstract][Full Text] [Related]
15. Changes in time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany and UK (2005-2010).
Kostev K; Rathmann W
Prim Care Diabetes; 2013 Oct; 7(3):229-33. PubMed ID: 23608219
[TBL] [Abstract][Full Text] [Related]
16. Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011.
Lee SJ; Stijacic-Cenzer I; Barnhart C; McClymont K; Steinman MA
J Am Med Dir Assoc; 2015 Oct; 16(10):898.e9-14. PubMed ID: 26272298
[TBL] [Abstract][Full Text] [Related]
17. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis.
Filion KB; Joseph L; Boivin JF; Suissa S; Brophy JM
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):973-6. PubMed ID: 19621344
[TBL] [Abstract][Full Text] [Related]
18. GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN.
Mitchell BD; He X; Sturdy IM; Cagle AP; Settles JA
Endocr Pract; 2016 Feb; 22(2):123-35. PubMed ID: 26484405
[TBL] [Abstract][Full Text] [Related]
19. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
[TBL] [Abstract][Full Text] [Related]
20. Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017.
Wilkinson S; Douglas I; Stirnadel-Farrant H; Fogarty D; Pokrajac A; Smeeth L; Tomlinson L
BMJ Open; 2018 Jul; 8(7):e022768. PubMed ID: 30056393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
